Dalfampridine Tablet, Film Coated, Extended Release
Product Images NDC 65862-863

4 FDA label images from Aurobindo Pharma Limited · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Dalfampridine (NDC 65862-863). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Figure 1 (Dalfampridine Fig1)

Figure 1 (Dalfampridine Fig1)
A bar chart titled 'Average walking speed change (%) from baseline during the double-blind phase of Trial 1.' It compares the percentage of patients achieving different levels of average percent increase in walking speed from baseline between placebo (N=72) and dalfampridine extended-release tablets 10 mg b.i.d. (N=224). The horizontal axis shows walking speed increase thresholds (≥0%, ≥10%, ≥20%, ≥30%, ≥40%, ≥50%, ≥60%), and the vertical axis shows the percentage of patients. Dalfampridine group patients reach higher percentages at each increase level compared to placebo.*
FDA Label Image

Figure 2 (Dalfampridine Fig2)

Figure 2 (Dalfampridine Fig2)
A bar graph titled 'Average walking speed change (%) from baseline during the double-blind phase of Trial 2' compares placebo and dalfampridine extended-release 10 mg tablets. The x-axis shows average percent increase in walking speed from baseline, and the y-axis shows percentage of patients in each group achieving these increases.*
FDA Label Image

Package Label-principal Display Panel (10 mg (60 Tablets Bottle))

Package Label-principal Display Panel (10 mg (60 Tablets Bottle))
Label for Dalfampridine Extended-Release Tablets 10 mg by Aurobindo Pharma Limited. The label indicates each film-coated tablet contains 10 mg of Dalfampridine USP. The package contains 60 tablets, with storage instructions and distributor information for Aurobindo Pharma USA, Inc. Dosage instructions advise consulting the package insert.*
FDA Label Image

Chemical Structure (Dalfampridine Str)

Chemical Structure (Dalfampridine Str)
Chemical structure of dalfampridine, showing a pyridine ring with an amino group (NH2) attached at the 2-position.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.